banner
HIV protease inhibitor ABT-378, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ901

HIV protease inhibitor ABT-378, Purity ≥98%

Synonym: 192725-17-0; HIV protease inhibitor; ABT-378

  • MDL: MFCD22628840
  • CAS Number: 192725-17-0
  • Compound CID: 92727
img
Product Size
10 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
ABT-378, soluble in DMSO and ethanol and insoluble in water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV protease.
Molecular Weight
628.8
Molecular Formula
C37H48N4O5
Targets
HIV protease: 1.3 pM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 116 mg/mL (184.48 mM); Water: Insoluble; Ethanol: 116 mg/mL (184.48 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
ABT-378 is used in research to inhibit HIV-1 protease, preventing viral protein processing and assembly.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0